Secondary Acute Myeloid Leukemia Is An Heterogeneous Subgroup Of Elderly Aml Where Patient'S Fitness Criteria And Eln Prognostic Stratification Can Be Applied To Guide Treatment Decisions: An Analysis Of 127 Patients By The Network Rete Ematologica Lombarda (Rel)

Background: According to the WHO classification, secondary acute myeloid leukemia (s-AML) includes cases occurring in patients (pts) receiving prior antineoplastic treatments as well as cases developing in pts with a history of previous hematology disorders, such as a myelodysplastic syndrome (MDS) or a chronic myeloproliferative disease (MPD).